Skip to content

Clinical trials

Phase 2 Emphysema trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Emphysema Phase: Phase 2 Country / region: United Kingdom Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20121
20182
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chelsea and Westminster NHS Foundation Trust2
Sanofi2
Altesa Biosciences, Inc.1
AstraZeneca1
Eli Lilly and Company1
Hoffmann-La Roche1
Mereo BioPharma1
Upstream Bio Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Emphysema10
Pulmonary Disease, Chronic Obstructive6
Lung Diseases3
alpha 1-Antitrypsin Deficiency3
Bronchitis, Chronic2
Blister1
Common Cold1
Enterovirus Infections1
Infections1
Lung Diseases, Obstructive1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.